Derrell D. Porter's most recent trade in Acumen Pharmaceuticals Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
Acumen Pharmaceuticals Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
Passage Bio Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
Acumen Pharmaceuticals Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option Grant (right to buy) | |
Passage Bio Inc | Derrell Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
Passage Bio Inc | Derrell Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 33,836 | 33,836 | - | - | Director Stock Option (Right to Buy) |